What Happened?
Philadelphia, PA-based Imvax Resigned Arthur Howe as Co-founder and Chief Financial Officer
Date of management change: August 09, 2021
Philadelphia, PA-based Imvax Resigned Arthur Howe as Co-founder and Chief Financial Officer
The approach is an autologous, cell-based treatment that activates the full array of patient-specific antigens, resulting in both an innate and adaptive immune response. The company`s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer with a significant unmet need. In parallel, the company is also progressing the platform in a select number of additional solid tumors where the unmet need remains great and where initial immunotherapy approaches have often failed to provide a significant benefit.
Arthur Howe is Co-founder and Chief Financial Officer at Imvax. Previously, Arthur held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Stanford John, Wood Austin, Prophater Kristen, Garcia Julie, Hoots-Hendrix Amy, Newman Katie, Falco Lin, Weiss Julia, Kingsley Bonnie, Wensel Cindy, Bostic Maribelle
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.